Simpson, Eric L.

Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials

Simpson, E. L., Lacour, J. ‐., Spelman, L., Galimberti, R., Eichenfield, L. F., Bissonnette, R., King, B. A., Thyssen, J. P., Silverberg, J. I., Bieber, T., et al. (2020) · British Journal of Dermatology

Dermatology and Skin DiseasesPsoriasis: Treatment and Pathogenesis

Cited by 396

Tezepelumab, an anti–thymic stromal lymphopoietin monoclonal antibody, in the treatment of moderate to severe atopic dermatitis: A randomized phase 2a clinical trial

Simpson, E. L., Parnes, J. R., She, D., Crouch, S., Rees, W., Mo, M., & van der Merwe, R. (2019) · Journal of the American Academy of Dermatology

Dermatology and Skin DiseasesAsthma and respiratory diseases

Cited by 328

The Harmonising Outcome Measures for Eczema (HOME) statement to assess clinical signs of atopic eczema in trials

Schmitt, J., Spuls, P. I., Thomas, K. S., Simpson, E., Furue, M., Deckert, S., Dohil, M., Apfelbacher, C., Singh, J. A., Chalmers, J., et al. (2014) · Journal of Allergy and Clinical Immunology

Dermatology and Skin DiseasesDelphi Technique in Research

Cited by 319

The harmonizing outcome measures for eczema (HOME) roadmap: a methodological framework to develop core sets of outcome measurements in dermatology

Schmitt, J., Apfelbacher, C., Spuls, P. I., Thomas, K. S., Simpson, E. L., Furue, M., Chalmers, J., & Williams, H. C. (2015) · Journal of Investigative Dermatology

Delphi Technique in ResearchDermatology and Skin Diseases

Cited by 230

A Pilot Study of an Oral Phosphodiesterase Inhibitor (Apremilast) for Atopic Dermatitis in Adults

Samrao, A., Berry, T. M., Goreshi, R., & Simpson, E. L. (2012) · Archives of Dermatology

Dermatology and Skin DiseasesAsthma and respiratory diseases

Cited by 166

Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative)

Chalmers, J. R., Simpson, E., Apfelbacher, C. J., Thomas, K. S., Kobyletzki, L., Schmitt, J., Singh, J. A., Svensson, Å., Williams, H. C., Abuabara, K., et al. (2016) · British Journal of Dermatology

Dermatology and Skin DiseasesDelphi Technique in Research

Cited by 125

Measurement Properties of the Hospital Anxiety and Depression Scale Used in Atopic Dermatitis in Adults

Silverberg, J. I., Gelfand, J. M., Margolis, D. J., Boguniewicz, M., Fonacier, L., Grayson, M. H., Ong, P. Y., Chiesa Fuxench, Z. C., & Simpson, E. L. (2019) · Journal of Investigative Dermatology

Dermatology and Skin DiseasesAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 32

Recommended core outcome instruments for health‐related quality of life, long‐term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting*

Thomas, K. S., Apfelbacher, C. A., Chalmers, J. R., Simpson, E., Spuls, P. I., Gerbens, L. A. A., Williams, H. C., Schmitt, J., Gabes, M., Howells, L., et al. (2021) · British Journal of Dermatology

Dermatology and Skin DiseasesDelphi Technique in Research

Cited by 13